Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging.
Saved in:
| Title: | Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. |
|---|---|
| Authors: | Ma TM; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Gafita A; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Shabsovich D; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Juarez J; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Grogan TR; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Thin P; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Armstrong W; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Sonni I; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Nguyen K; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Lok V; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Reiter RE; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA., Rettig MB; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA; Department of Medicine, Division of Hematology-Oncology, UCLA Medical Center, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Kupelian PA; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Yang DD; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA., Muralidhar V; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA., Chu C; Department of Urology, UCSF Medical Center, San Francisco, CA, USA., Feng F; Department of Urology, UCSF Medical Center, San Francisco, CA, USA; Department of Radiation Oncology, UCSF Medical Center, San Francisco, CA, USA., Savjani R; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Deng J; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Parikh NR; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA., Elashoff D; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu. |
| Source: | European urology oncology [Eur Urol Oncol] 2022 Feb; Vol. 5 (1), pp. 100-103. Date of Electronic Publication: 2021 Feb 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33602654 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ma+TM%22">Ma TM</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gafita+A%22">Gafita A</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Shabsovich+D%22">Shabsovich D</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Juarez+J%22">Juarez J</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Grogan+TR%22">Grogan TR</searchLink>; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Thin+P%22">Thin P</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Armstrong+W%22">Armstrong W</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sonni+I%22">Sonni I</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nguyen+K%22">Nguyen K</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lok+V%22">Lok V</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Reiter+RE%22">Reiter RE</searchLink>; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rettig+MB%22">Rettig MB</searchLink>; Department of Urology, UCLA Medical Center, Los Angeles, CA, USA; Department of Medicine, Division of Hematology-Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Steinberg+ML%22">Steinberg ML</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kupelian+PA%22">Kupelian PA</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Yang+DD%22">Yang DD</searchLink>; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Muralidhar+V%22">Muralidhar V</searchLink>; Harvard Radiation Oncology Program, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Chu+C%22">Chu C</searchLink>; Department of Urology, UCSF Medical Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Feng+F%22">Feng F</searchLink>; Department of Urology, UCSF Medical Center, San Francisco, CA, USA; Department of Radiation Oncology, UCSF Medical Center, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Savjani+R%22">Savjani R</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Deng+J%22">Deng J</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Parikh+NR%22">Parikh NR</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nickols+NG%22">Nickols NG</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Elashoff+D%22">Elashoff D</searchLink>; Statistics Core, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Czernin+J%22">Czernin J</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Calais+J%22">Calais J</searchLink>; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA Medical Center, Los Angeles, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kishan+AU%22">Kishan AU</searchLink>; Department of Radiation Oncology, UCLA Medical Center, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724904%22">European urology oncology</searchLink> [Eur Urol Oncol] 2022 Feb; Vol. 5 (1), pp. 100-103. <i>Date of Electronic Publication: </i>2021 Feb 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+B%2EV%22">Elsevier B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101724904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2588-9311 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225889311%22">25889311 </searchLink><i>NLM ISO Abbreviation: </i>Eur Urol Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33602654 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.euo.2021.01.006 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 100 Titles: – TitleFull: Identifying the Best Candidates for Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as the Primary Staging Approach Among Men with High-risk Prostate Cancer and Negative Conventional Imaging. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ma TM – PersonEntity: Name: NameFull: Gafita A – PersonEntity: Name: NameFull: Shabsovich D – PersonEntity: Name: NameFull: Juarez J – PersonEntity: Name: NameFull: Grogan TR – PersonEntity: Name: NameFull: Thin P – PersonEntity: Name: NameFull: Armstrong W – PersonEntity: Name: NameFull: Sonni I – PersonEntity: Name: NameFull: Nguyen K – PersonEntity: Name: NameFull: Lok V – PersonEntity: Name: NameFull: Reiter RE – PersonEntity: Name: NameFull: Rettig MB – PersonEntity: Name: NameFull: Steinberg ML – PersonEntity: Name: NameFull: Kupelian PA – PersonEntity: Name: NameFull: Yang DD – PersonEntity: Name: NameFull: Muralidhar V – PersonEntity: Name: NameFull: Chu C – PersonEntity: Name: NameFull: Feng F – PersonEntity: Name: NameFull: Savjani R – PersonEntity: Name: NameFull: Deng J – PersonEntity: Name: NameFull: Parikh NR – PersonEntity: Name: NameFull: Nickols NG – PersonEntity: Name: NameFull: Elashoff D – PersonEntity: Name: NameFull: Czernin J – PersonEntity: Name: NameFull: Calais J – PersonEntity: Name: NameFull: Kishan AU IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2022 Feb Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 2588-9311 Numbering: – Type: volume Value: 5 – Type: issue Value: 1 Titles: – TitleFull: European urology oncology Type: main |
| ResultId | 1 |
